Use of Lopinavir/ritonavir Associated with Ergotamine Resulting in Foot Amputation: Brief Communication
نویسندگان
چکیده
A 32-year-old female, was diagnosed in 2004 with a C1 HIV1 infection, using zidovudine/lamivudine 300/150 mg BID and lopinavir/ritonavir 400/100 mg BID, in addition to prophylaxis with trimethoprim-sulfamethoxazole 800/160 mg QD, but no prophylaxis with macrolide antibiotics. The patient presented with a severe headache and was prescribed two capsules of the anti-migraine drug Ormigrein™, which contained ergotamine tartrate 1 mg, caffeine 100 mg, paracetamol 220 mg, hyoscyamine sulfate 87.5 mcg, and atropine sulfate 12.5 mcg. Afterwards she was prescribed one capsule of Ormigrein every 30 minutes for a total of six capsules a day. The patient took the medication as prescribed but developed a pain in her left ankle three days later, which evolved to the need for amputation.
منابع مشابه
Incidence of Cardiac Dysrhythmia in COVID-19 Patients Treated with Conventional Medications – A Brief Report of 58 Patients
Introduction: When World Health Organization (WHO) declared that Covid-19 is a pandemic, a wide range of drugs, including antiviral drugs and antibiotics have been taken to treat this disease. This study aimed to evaluate the incidence of cardiac dysrhythmias due to the conventional medications in 58 COVID -19 patients. Methods: This study is a cross-sectional analytical study was performed to...
متن کاملFour-limb acute ischemia induced by ergotamine in an AIDS patient treated with protease inhibitors.
A 32-year-old man infected with HIV presented to the emergency department of our hospital reporting pain, coldness, paresthesias, and cyanosis in both feet and hands. The symptoms had started 3 days before, with lower extremities claudication at 200 m, which progressed to rest pain the day of admission; it was worse on the right foot. He was on chronic antiretroviral therapy with 300 mg QID ten...
متن کاملRandomised Pharmacokinetic Trial of Rifabutin with Lopinavir/Ritonavir-Antiretroviral Therapy in Patients with HIV-Associated Tuberculosis in Vietnam
BACKGROUND Rifampicin and protease inhibitors are difficult to use concomitantly in patients with HIV-associated tuberculosis because of drug-drug interactions. Rifabutin has been proposed as an alternative rifamycin, but there is concern that the current recommended dose is suboptimal. The principal aim of this study was to compare bioavailability of two doses of rifabutin (150 mg three times ...
متن کاملPharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patients.
Sir, Some degree of hepatotoxicity was associated with the use of protease inhibitors (PIs) soon after their introduction into the antiretroviral market. Although under the term hepatotoxicity a variety of heterogeneous conditions of liver damage may be included, here the definition is broadly applied to any form of alteration of liver function tests (LFTs). The clinical use of lopinavir/ritona...
متن کاملTreatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study
Objectives. To investigate the possible benefits and adverse effects of the addition of lopinavir/ritonavir to a standard treatment protocol for the treatment of severe acute respiratory syndrome. Design. Retrospective matched cohort study. Setting. Four acute regional hospitals in Hong Kong. Patients and methods. Seventy-five patients with severe acute respiratory syndrome treated with lopinav...
متن کامل